PQ

Pure Biologics SAMUN Pure Stock Report

Last reporting period 30 Sep, 2023

Updated 22 Oct, 2024

Last price

Market cap $B

0.019

Micro

Exchange

XMUN - Boerse Muenchen

PQB.MU Stock Analysis

PQ

Uncovered

Pure Biologics SA is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

-63/100

Low score

Market cap $B

0.019

Dividend yield

Shares outstanding

3.214 B

Pure Biologics SA is a biopharmaceutical company, which engages in the research and development of innovative biological medicines and medical devices for use therapeutic and diagnostic tests. The company is headquartered in Wroclaw, Woj. Dolnoslaskie and currently employs 101 full-time employees. The company went IPO on 2018-12-11. The firm was founded in August 2010 and is located in Wroclaw, Poland.

View Section: Eyestock Rating